Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Certain drugs change freshwater snail shells to a "banana" shape.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

A group has developed therapies that show promise for treating cancer and various other conditions.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

DHEA improved brain function and behavior in old monkeys and had additional health benefits.

Red fluorescence in AGA scalps is linked to different microbes.

Plant extracts in shampoo improved hair thickness and density in men with hair loss.

Stress may trigger hair loss by affecting immune protection in hair follicles.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Heat treatment increases hair loss in certain mice.

High mTORC1 activity slows hair growth and causes it to lose color.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.